Evidence map›Paper›PMID 42685066›Full record

ArticlePLoS neglected tropical diseases2026

Chikungunya waves in 2025 signal risk of endemicity in China.

Kok Keng Tee, Dongkui Mu, Xueshan Xia

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kok Keng TeeYunnan Provincial Key Laboratory of Public Health and Biosafety, Yunnan Provincial Key Laboratory of Cross-Border Infectious Diseases Control and Drug Innovation, School of Public Health, Kunming Medical University, Yunnan, China.ORCID https://orcid.org/0000-0002-7923-5448
Dongkui MuYunnan Provincial Key Laboratory of Public Health and Biosafety, Yunnan Provincial Key Laboratory of Cross-Border Infectious Diseases Control and Drug Innovation, School of Public Health, Kunming Medical University, Yunnan, China.
Xueshan XiaYunnan Provincial Key Laboratory of Public Health and Biosafety, Yunnan Provincial Key Laboratory of Cross-Border Infectious Diseases Control and Drug Innovation, School of Public Health, Kunming Medical University, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chikungunya virus (CHIKV) transmission in Guangdong, southern China, intensified markedly in 2025, with successive outbreak waves in Foshan and Jiangmen followed by wider dissemination across all 21 prefectures during a peak domestic travel period. By late 2025, more than 25,000 cases had been reported, suggesting a departure from the historically import-driven and geographically limited outbreaks previously observed in China. These observations raise the possibility of an early transition towards more sustained transmission, although repeated introductions followed by local amplification remain an alternative explanation. Key contributing factors include mobility-associated amplification, climate variability, flood-related expansion of mosquito breeding habitats, favourable urban ecology, and incomplete interruption of transmission during cooler months. Although winter temperatures are suboptimal for sustained transmission, vector persistence and possible vertical viral transmission may permit low-level circulation between epidemic waves. In this context, distinguishing repeated importation from local persistence becomes critical. Preventing endemic establishment will require sustained inter-epidemic surveillance, anticipatory vector control, and clearer policy pathways for deployable vaccination strategies.

Indexed as

Chikungunya FeverChikungunya virusEndemic DiseasesAnimalsChinaDisease OutbreaksHumansMosquito VectorsSeasons

Identifiers

PMID42685066
PMCPMC13537560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.